Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Exosome Technology Acquired for TBI, Stroke Therapies

Stroke circulation

A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes. . . . → Read More: Exosome Technology Acquired for TBI, Stroke Therapies

Engineered Polio Virus Tested as Brain Cancer Treatment

Brain tumor graphic

Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

Patent Awarded for Nasal Delivered Cancer Immunotherapy

U.S. Patent and Trademark Office

A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent. . . . → Read More: Patent Awarded for Nasal Delivered Cancer Immunotherapy

Immunotherapy Trial Shows Increased Brain Cancer Survival

Robert Fenstermaker and Michael Ciesielski

Results from a clinical trial show an experimental treatment for an aggressive form of brain cancer that harnesses the immune system extends patients’ survival, when combined with standard cancer care. . . . → Read More: Immunotherapy Trial Shows Increased Brain Cancer Survival

Long-Term Effects Shown from Hemophilia Gene Therapy

Drop of blood

Participants in a clinical trial testing a one-time genetic therapy to treat a rare form of hemophilia sharply reduced their bleeding incidents after a year, with few adverse effects, none considered serious. . . . → Read More: Long-Term Effects Shown from Hemophilia Gene Therapy

Univ. Licenses Barrett’s Esophagus Detection Device

Cancer magnified

A medical device company is licensing a minimally-invasive technology developed in university labs for detection of Barrett’s esophagus, a condition that often leads to esophageal cancer. . . . → Read More: Univ. Licenses Barrett’s Esophagus Detection Device

Genetic Repair Company Starts-Up, Gains $87 Million

David Liu

A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million

Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Collecting soil samples

Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal